Overexpression of bcl-2 attenuates mpp+, but not 6-odha, induced cell death in a dopaminergic neuronal cell line

Young J. Oh; Shou C. Wong; Mark Moffat; Karen L. O’Malley

doi:10.1006/nbdi.1995.0017

Overexpression of bcl-2 attenuates mpp⁺, but not 6-odha, induced cell death in a dopaminergic neuronal cell line

Young J. Oh, Shou C. Wong, Mark Moffat, Karen L. O’Malley

Department of Systems Biology

Research output: Contribution to journal › Article › peer-review

54 Citations (Scopus)

Abstract

In order to investigate the role of Bcl-2 in dopaminergic cells, we established a dopaminergic neuronal cell line (MN9D) stably expressing human Bcl-2 (MN9D/Bcl-2) or neomycin (MN9D/Neo). Overexpression of Bcl-2 in MN9D cells attenuated cell death due to treatment of mitochondrial electron transport inhibitors including N-methyl-4-phenylpyridinium, whereas it did not prevent cell death induced by reagents generating reactive oxygen species including 6-hydroxy-dopamine. Moreover, the rate of glucose uptake in MN9D/Bcl-2 was significantly lower than that in MN9D/Neo after MPP⁺ treatment. Thus, Bcl-2 may counter aberrations in mitochondrial electron transfer processes by altering energy metabolism within the MN9D cells.

Original language	English
Pages (from-to)	157-167
Number of pages	11
Journal	Neurobiology of Disease
Volume	2
Issue number	3
DOIs	https://doi.org/10.1006/nbdi.1995.0017
Publication status	Published - 1995

Bibliographical note

Funding Information:
We thank Drs Stanley J. Korsmeyer, Dennis W. Choi, Richard Todd and J. Koh for thoughtful discussions and critical reading of parts of this manuscript, Dr E. M. Johnson for many valuable discussions and suggestions, and for the use of equipment, and T. L. Deckwerth for his technical assistance. We also gratefully acknowledge Drs A. Heller, L.Wong and D. Hoffman not only for providing us with the MN9D cell line but also for their many insightful comments in using this system. A portion of this work is published in abstract form. Supported by NIA 44626, MH45530 and NS54982.

All Science Journal Classification (ASJC) codes

Neurology

Access to Document

10.1006/nbdi.1995.0017

Cite this

@article{53bf4943c37e4c34adde6e2d920b5a66,

title = "Overexpression of bcl-2 attenuates mpp+, but not 6-odha, induced cell death in a dopaminergic neuronal cell line",

abstract = "In order to investigate the role of Bcl-2 in dopaminergic cells, we established a dopaminergic neuronal cell line (MN9D) stably expressing human Bcl-2 (MN9D/Bcl-2) or neomycin (MN9D/Neo). Overexpression of Bcl-2 in MN9D cells attenuated cell death due to treatment of mitochondrial electron transport inhibitors including N-methyl-4-phenylpyridinium, whereas it did not prevent cell death induced by reagents generating reactive oxygen species including 6-hydroxy-dopamine. Moreover, the rate of glucose uptake in MN9D/Bcl-2 was significantly lower than that in MN9D/Neo after MPP+ treatment. Thus, Bcl-2 may counter aberrations in mitochondrial electron transfer processes by altering energy metabolism within the MN9D cells.",

author = "Oh, {Young J.} and Wong, {Shou C.} and Mark Moffat and O{\textquoteright}Malley, {Karen L.}",

note = "Funding Information: We thank Drs Stanley J. Korsmeyer, Dennis W. Choi, Richard Todd and J. Koh for thoughtful discussions and critical reading of parts of this manuscript, Dr E. M. Johnson for many valuable discussions and suggestions, and for the use of equipment, and T. L. Deckwerth for his technical assistance. We also gratefully acknowledge Drs A. Heller, L.Wong and D. Hoffman not only for providing us with the MN9D cell line but also for their many insightful comments in using this system. A portion of this work is published in abstract form. Supported by NIA 44626, MH45530 and NS54982.",

year = "1995",

doi = "10.1006/nbdi.1995.0017",

language = "English",

volume = "2",

pages = "157--167",

journal = "Neurobiology of Disease",

issn = "0969-9961",

publisher = "Academic Press Inc.",

number = "3",

}

TY - JOUR

T1 - Overexpression of bcl-2 attenuates mpp+, but not 6-odha, induced cell death in a dopaminergic neuronal cell line

AU - Oh, Young J.

AU - Wong, Shou C.

AU - Moffat, Mark

AU - O’Malley, Karen L.

N1 - Funding Information: We thank Drs Stanley J. Korsmeyer, Dennis W. Choi, Richard Todd and J. Koh for thoughtful discussions and critical reading of parts of this manuscript, Dr E. M. Johnson for many valuable discussions and suggestions, and for the use of equipment, and T. L. Deckwerth for his technical assistance. We also gratefully acknowledge Drs A. Heller, L.Wong and D. Hoffman not only for providing us with the MN9D cell line but also for their many insightful comments in using this system. A portion of this work is published in abstract form. Supported by NIA 44626, MH45530 and NS54982.

PY - 1995

Y1 - 1995

N2 - In order to investigate the role of Bcl-2 in dopaminergic cells, we established a dopaminergic neuronal cell line (MN9D) stably expressing human Bcl-2 (MN9D/Bcl-2) or neomycin (MN9D/Neo). Overexpression of Bcl-2 in MN9D cells attenuated cell death due to treatment of mitochondrial electron transport inhibitors including N-methyl-4-phenylpyridinium, whereas it did not prevent cell death induced by reagents generating reactive oxygen species including 6-hydroxy-dopamine. Moreover, the rate of glucose uptake in MN9D/Bcl-2 was significantly lower than that in MN9D/Neo after MPP+ treatment. Thus, Bcl-2 may counter aberrations in mitochondrial electron transfer processes by altering energy metabolism within the MN9D cells.

AB - In order to investigate the role of Bcl-2 in dopaminergic cells, we established a dopaminergic neuronal cell line (MN9D) stably expressing human Bcl-2 (MN9D/Bcl-2) or neomycin (MN9D/Neo). Overexpression of Bcl-2 in MN9D cells attenuated cell death due to treatment of mitochondrial electron transport inhibitors including N-methyl-4-phenylpyridinium, whereas it did not prevent cell death induced by reagents generating reactive oxygen species including 6-hydroxy-dopamine. Moreover, the rate of glucose uptake in MN9D/Bcl-2 was significantly lower than that in MN9D/Neo after MPP+ treatment. Thus, Bcl-2 may counter aberrations in mitochondrial electron transfer processes by altering energy metabolism within the MN9D cells.

UR - http://www.scopus.com/inward/record.url?scp=0029311830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029311830&partnerID=8YFLogxK

U2 - 10.1006/nbdi.1995.0017

DO - 10.1006/nbdi.1995.0017

M3 - Article

C2 - 9173999

AN - SCOPUS:0029311830

SN - 0969-9961

VL - 2

SP - 157

EP - 167

JO - Neurobiology of Disease

JF - Neurobiology of Disease

IS - 3

ER -